Authored By: Sarah
25 Oct 2024

increased demand for mabs is driving the Protein Therapeutics Market

Latest News:- Protein Therapeutics Market: mAbs is expected to lead the Product segment during 2024-2028

Technavio analyzes that the Protein Therapeutics Market is expected to grow at a CAGR of 9.47% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 172.8 billion.There are various factors that contribute to the growth of the market. The Protein Therapeutics Market is experiencing significant growth due to the increasing demand for monoclonal antibodies (mAbs). These therapeutic proteins are widely used in the healthcare industry for the treatment of various diseases, including cancer and autoimmune disorders. Their high specificity and efficacy make them a preferred choice over traditional small molecule drugs. The market is expected to continue its upward trajectory as research and development efforts in this field intensify.

In the dynamic and innovative landscape of the Protein Therapeutics Market, the rising incidence of diseases such as rheumatoid arthritis, cancers, systemic lupus erythematosus, multiple sclerosis, Crohn's disease, psoriasis, ulcerative colitis, transplantation, and diabetic cases, is driving market growth. The escalating burden of diseases like cancer, attributed to lifestyle factors such as smoking, alcohol consumption, and sedentary work, is fueling demand for advanced treatment options. Next-generation antibodies, including GAZYVA, BLINCYTO, Removab, and POTELIGEO, are gaining popularity due to their efficacy in treating cancer. Advanced Drug Conjugates (ADCs), which are highly effective cytotoxic drugs linked to monoclonal antibodies, are revolutionizing disease treatment. Seattle Genetics' SGEN, ImmunoGen's IMGN, and Immunomedics' IMMU are among the leading companies investing in novel ADC technologies. The increasing adoption of ADCs in drug development is significantly contributing to the revenue growth of the global Protein Therapeutics Market. Protein synthesis and formulation techniques, despite their high cost and complex procedures, remain crucial components of the market's growth trajectory. 

Know which region is leading the market growth by requesting a sample report

Protein Therapeutics Market Segmentation

  • Product
    • mAbs
    • Human insulin
    • Erythropoeitin
    • Clotting factors
    • Others
  • Application
    • Metabolic disorders
    • Immunologic disorders
    • Hematological disorders
    • Cancer
    • Genetic disorders
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Biocon Ltd.
  • Biogen Inc.
  • Bristol Myers Squibb Co.
  • Celltrion Healthcare Co. Ltd.
  • Creative Biolabs
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Intas Pharmaceuticals Ltd.
  • Ipsen Pharma
  • Johnson and Johnson Services Inc.
  • LGM Pharma LLC
  • Midas Pharma GmbH
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • PV Pharma Healthcare Pvt. Ltd.
  • Sanofi SA

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Protein Therapy Market encompasses a range of medicines and treatments for chronic diseases, including cancer, diabetes, autoimmune disorders, and cardiovascular diseases. These therapies utilize both genetically engineered proteins and natural proteins, such as sugars and molecules, to modify the activity duration of therapeutic protein drugs. Major healthcare institutions turn to protein therapies for treating immunological diseases, hematological disorders, and metabolic disorders like diabetes. Monoclonal antibodies segment dominates the market, with chemotherapy and recombinant proteins following closely. Developing economies are expected to drive growth in this versatile market for quality drugs.

Market Research Overview

The Protein Therapeutics market is a significant segment of the larger pharmaceuticals industry, focusing on the research, development, and production of innovative biological drugs for the treatment of chronic diseases, including cancer, diabetes, autoimmune disorders, and cardiovascular diseases. Major healthcare institutions, pharmaceutical firms, and research centers collaborate to advance protein therapeutics, aiming for improved patient outcomes and reduced healthcare expenditure. The global pharmaceuticals market, which encompasses entities involved in the manufacture and provision of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is expected to grow substantially due to demographic shifts, with the aging population in major markets such as the US and Europe. By 2050, approximately one-quarter of the US population and a similar proportion in Europe are projected to be over 60 years old, necessitating increased investment in healthcare infrastructure and advanced treatments. Skilled working professionals play a crucial role in driving the growth of this sector through their expertise and contributions to research and development.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio